Table 1.
Overview of international guidelines (CCS: corticosteroids; NSAIDs: non-steroidal anti-inflammatory drugs; SSRI: Serotonin-Noradrenalin-Reuptake-Inhibitors; TCAs: tricyclic antidepressants)
| Guidelines | NSAID (selective) | NSAID (non selective) |
Paracetamol | Opioids (weak) | Opioids (strong) | CCS | Antibiotics | Duloxetine | Gabapentinoids | SSRIs | TCAs | Myorelaxans |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada [30] | favour | favour | favour | inconclusive | inconclusive | against | against | against | against | against | favour | favour |
| USA [42] | favour | favour | against | favour | favour | inconclusive | against | inconclusive | - | - | - | against |
| USA, Canada, Chile, Switzerland [43] | inconclusive | inconclusive | against | inconclusive | inconclusive | against | - | against | against | - | inconclusive | against |
| North America [44] | inconclusive | favour | against | inconclusive | inconclusive | against | against | against | inconclusive | - | against | against |
| USA [45] | inconclusive | inconclusive | inconclusive | against | against | against | - | favour | inconclusive | - | favour | inconclusive |
| ICSI/USA | inconclusive | inconclusive | inconclusive | inconclusive | inconclusive | inconclusive | inconclusive | - | - | inconclusive | inconclusive | - |
| Denmark [12] | inconclusive | inconclusive | inconclusive | inconclusive | inconclusive | inconclusive | inconclusive | - | - | inconclusive | inconclusive | - |
| UK [46] | favour | favour | against | favour | inconclusive | inconclusive | - | - | against | against | against | against |
| France [47] | favour | favour | favour | favour | favour | inconclusive | against | - | against | against | against | against |
| Germany [9] | favour | favour | against | favour | favour | - | - | - | - | - | - | - |
| Belgium [48] | favour | favour | against | favour | inconclusive | inconclusive | against | - | against | against | against | against |